Pharmacovigilance programme of India

Pharmacovigilance programme of India

The monitoring and reporting of adverse drug reactions (ADRs) through pharmacovigilance is vital to patient safety and rational prescribing. In India, Central Drugs Standard Control Organization (CDSCO) initiated Pharmacovigilance Programme of India (PvPI) to report ADRs through ADRs monitoring cent...

Full description

Bibliographic Details
Main Authors:	Kalaiselvan Vivekanandan, Jai Prakash, Gyanendra Nath Singh
Format:	Article
Language:	English
Published:	Archives of Global Professionals 2012-01-01
Series:	Archives of Pharmacy Practice
Subjects:	Pharmacovigilance ADRs VigiFlow Indian Pharmacopoeia Commission Central Drugs Standard Control Organization
Online Access:	http://www.archivepp.com/article.asp?issn=2045-080X;year=2012;volume=3;issue=3;spage=229;epage=232;aulast=Vivekanandan;type=0

Similar Items

An update on the Pharmacovigilance Programme of India
by: Ratan J Lihite, et al.
Published: (2015-09-01)

A pharmacovigilance Study on Critically Ill Patients Admitted In Beni-Suef University Teaching Hospital.
by: Alshimaa Mohamed Abdelmohymen, et al.
Published: (2021-06-01)

Risk Factors for Respiratory Depression Associated with Tramadol Based on the Global Pharmacovigilance Database (VigiBase)
by: Sunny Park, et al.
Published: (2024-02-01)

Pivotal role of Pharmacovigilance Programme of India in containment of antimicrobial resistance in India
by: Vijit Agrawal, et al.
Published: (2019-01-01)

Studi pharmacovigilance obat di puskesmas X Yogyakarta
by: Mustika Muthaharah, et al.
Published: (2017-06-01)

Assessment of knowledge and attitude on pharmacovigilance among the healthcare professional and pharmacy student at Dharan
by: Shankar Thapa
Published: (2022-12-01)

Assessment of Knowledge, Attitude and Barriers towards Pharmacovigilance among Physicians and Pharmacists of Abbottabad, Pakistan
by: Akash Syed, et al.
Published: (2018-03-01)

Hubungan Pengetahuan Tenaga Kesehatan Tentang Pharmacovigilance Terhadap Sikap Pelaporan ADR di Kota Semarang
by: Farroh Bintang Sabiti, et al.
Published: (2023-08-01)

Safety monitoring of local anaesthetic drugs from the perspective of Pharmacovigilance Programme of India
by: Pramod Kumar, et al.
Published: (2017-01-01)

An evaluation of the knowledge and perceptions of pharmacy students on pharmacovigilance activities in Nigeria
by: Kanayo P. Osemene, et al.
Published: (2017-07-01)

Prospects of consumer-initiated adverse drug reaction reporting in cardiovascular pharmacovigilance
by: Vinu Wilson, et al.
Published: (2015-01-01)

Knowledge, attitude and practice towards pharmacovigilance among ayurveda physicians and teachers of Gujarat State: A cross sectional study
by: Rabinarayan Acharya, et al.
Published: (2022-01-01)

Preventability, predictability, severity and causality assessment of adverse drug reactions reported from a teaching hospital in chhattisgarh: A retrospective analysis
by: Yogendra Keche, et al.
Published: (2021-01-01)

Pharmacovigilance in India, Uganda and South Africa with Reference to WHO’s Minimum Requirements
by: Karen Maigetter, et al.
Published: (2015-05-01)

Hepatic Models in Precision Medicine: An African Perspective on Pharmacovigilance
by: Tracey Hurrell, et al.
Published: (2022-04-01)

Drug safety alerts of pharmacovigilance programme of India: A scope for targeted spontaneous reporting in India
by: Prasad Thota, et al.
Published: (2018-01-01)

An OMOP-CDM based pharmacovigilance data-processing pipeline (PDP) providing active surveillance for ADR signal detection from real-world data sources
by: Hyunah Shin, et al.
Published: (2021-05-01)

Smartphone-based mobile applications for adverse drug reactions reporting: global status and country experience
by: Ayako Fukushima, et al.
Published: (2022-05-01)

Quality of Active versus Spontaneous Reporting of Adverse Drug Reactions in Pediatric Patients: Relevance for Pharmacovigilance and Knowledge in Pediatric Medical Care
by: Anne T. M. Dittrich, et al.
Published: (2022-09-01)

A study on adverse drug reactions in a tertiary care hospital of Northeast India
by: Ratan J. Lihite, et al.
Published: (2017-06-01)

Workshop on Adverse Drug Reaction Reporting, Pharmacovigilance and Its Implementation in Cancer Hospital in Nepal: An Event Report
by: Shrestha S, et al.
Published: (2020-01-01)

Intravitreal Anti-VEGF Drugs and Signals of Dementia and Parkinson-Like Events: Analysis of the VigiBase Database of Spontaneous Reports
by: Janet Sultana, et al.
Published: (2020-03-01)

Knowledge, attitude and practice of hospital pharmacists towards pharmacovigilance and adverse drug reaction reporting in Najran, Saudi Arabia
by: Ali Mohamed Alshabi, et al.
Published: (2022-07-01)

Using Machine Learning for Pharmacovigilance: A Systematic Review
by: Patrick Pilipiec, et al.
Published: (2022-01-01)

Pharmacovigilance Programme of India
by: Duvvuru Ashok Kumar, et al.
Published: (2015-01-01)

A Retrospective Analysis of Reporting of Adverse Drug Reactions in a Tertiary Care Teaching Hospital: One Year Survey
by: Anuj Kumar Pathak, et al.
Published: (2016-08-01)

Analysis of Hepatobiliary Disorder Reports Associated With the Use of Herbal Medicines in the Global Suspected ADR Database Vigibase
by: Florence van Hunsel, et al.
Published: (2019-11-01)

Drug-induced fall risk in older patients: A pharmacovigilance study of FDA adverse event reporting system database
by: Shuang Zhou, et al.
Published: (2022-11-01)

Knowledge, attitude and perception/practices (KAP) of medical practitioners in India towards adverse drug reaction (ADR) reporting
by: Mala Kharkar, et al.
Published: (2012-01-01)

Knowledge, perceptions and practices of pharmacovigilance amongst community and hospital pharmacists in a selected district of North West Province, South Africa
by: M.C. Joubert, et al.
Published: (2016-10-01)

Knowledge, perceptions and practices of pharmacovigilance amongst community and hospital pharmacists in a selected district of North West Province, South Africa
by: M.C. Joubert, et al.
Published: (2016-12-01)

Public-private partnership (3Ps) in ensuring safe use of medicines: An Indian experience
by: Vivekanandan Kalaiselvan, et al.
Published: (2022-08-01)

Ensuring the quality of medicines in India: An update on the development, modernization, and harmonization of drug standards in the Indian Pharmacopoeia
by: Gaurav Pratap Singh Jadaun, et al.
Published: (2023-12-01)

Awareness among tertiary care doctors about Pharmacovigilance Programme of India: Do endocrinologists differ from others?
by: Pramod Kumar Sharma, et al.
Published: (2016-01-01)

Safety Profile of Medicines Used for the Treatment of Drug-Resistant Tuberculosis: A Descriptive Study Based on the WHO Database (VigiBase<sup>®</sup>)
by: Alemayehu Lelisa Duga, et al.
Published: (2023-04-01)

Reporting Antimicrobial-Related Adverse Drug Events in Jordan: An Analysis from the VigiBase Database
by: Nizar Mahmoud Mhaidat, et al.
Published: (2023-03-01)

Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database
by: Rosanna Ruggiero, et al.
Published: (2020-06-01)

Organisation of the Russian Pharmacovigilance System: Survey of Pharmacovigilance Officers
by: A. E. Krasheninnikov, et al.
Published: (2021-10-01)

Immune Checkpoint Inhibitors and Pregnancy: Analysis of the VigiBase<sup>®</sup> Spontaneous Reporting System
by: Roberta Noseda, et al.
Published: (2022-12-01)

Characteristic analysis of adverse reactions of five anti-TNFɑ agents: a descriptive analysis from WHO-VigiAccess
by: Mingming Li, et al.
Published: (2023-07-01)